TQB2450-II-05, NCT04306926: A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer |
|
|
| Not yet recruiting | 2 | 59 | RoW | TQB2450, SBRT | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Oligometastatic Non-small Cell Lung Cancer | 10/22 | 05/23 | | |
NCT06020066: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI |
|
|
| Recruiting | 2 | 202 | RoW | EGFR-TK Inhibitor, Stereotactic radiotherapy | Fudan University | Brain Metastases, Non-small Cell Lung Cancer | 08/28 | 08/29 | | |
NCT06301100: Single-center, Prospective Study on the Identification and Delineation of Brain and Lung Tumors and At-Risk Organs, and Functional Testing of Surrounding Tissues Based on Dual-Energy CT |
|
|
| Recruiting | N/A | 50 | RoW | Dual energy CT after routine simulation | Tianjin Medical University Cancer Institute and Hospital | Image Quality and Contouring Accuracy of the Tumor in Radiotherapy | 04/24 | 12/24 | | |
NCT05787522: Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs At Risk |
|
|
| Completed | N/A | 500 | RoW | contouring of thoracic organs at risk | Tianjin Medical University Cancer Institute and Hospital, Guangzhou Perception Vision Medical Technology Co. Ltd, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Shanxi Province Cancer Hospital, Fifth Affiliated Hospital, Sun Yat-Sen University, Wuhan Union Hospital, China | Lung Cancer, Breast Cancer, Esophageal Cancer | 07/23 | 03/24 | | |